Ignite Creation Date:
2025-12-24 @ 11:19 PM
Ignite Modification Date:
2026-02-03 @ 3:39 PM
Study NCT ID:
NCT03541356
Status:
COMPLETED
Last Update Posted:
2020-08-12
First Post:
2018-04-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Therapeutic Potential for Intranasal Levodopa in Parkinson's Disease -Off Reversal
Sponsor:
Impel Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Parkinson's Disease | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Parkinsons | View |
| None | L-dopa | View |
| None | levodopa | View |
| None | ON | View |
| None | OFF | View |
| None | PD | View |
| None | POD device | View |
| None | I231 | View |
| None | benserazide | View |
| None | Precision olfactory delivery | View |
| None | MDS-UPDRS | View |
| None | Carbidopa | View |
| None | DCI | View |
| None | Decarboxylase Inhibitor | View |